Showing results (41-50 of 323) with videos related to
Sort By:
Pageof 33
Cancer Treatment Reports|September 1, 1977
Current cooperative clinical trials in the non-Hodgkin's lymphomasF M Muggia, H L Davis, M RozencweigCancer Research|March 1, 1986
Synergistic activity of doxorubicin and the bisdioxopiperazine (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187) against the murine sarcoma S180 cell lineS Wadler, M D Green, F M MuggiaJournal of the National Cancer Institute|March 5, 1998
Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro studyJ Szebeni, F M Muggia, C R AlvingAnnals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1993
Protracted drug infusions in cancer treatment: an appraisal of 5-fluorouracil, doxorubicin, and platinumsE DelaFlor-Weiss, B Uziely, F M MuggiaHead & Neck Surgery|January 1, 1980
Role of chemotherapy in head and neck cancer: systemic use of single agents and combinations in advanced diseaseF M Muggia, M Rozencweig, A E LouieAnnals of the New York Academy of Sciences|December 13, 1996
Camptothecin and its analogs. An overview of their potential in cancer therapeuticsF M Muggia, I Dimery, S G ArbuckRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1980
The rediscovery of DON (6-diazo-5-oxo-L-norleucine)D L Kisner, R Catane, F M MuggiaCancer Research|November 26, 1997
Cellular adaptation to drug exposure: evolution of the drug-resistant phenotypeY Matsumoto, H Takano, T FojoThe Journal of Clinical Endocrinology and Metabolism|January 14, 2000
Construction of gene therapy vectors targeting adrenocortical cells: enhancement of activity and specificity with agents modulating the cyclic adenosine 3',5'-monophosphate pathwayY Chuman, Z Zhan, T FojoBiochemical and Biophysical Research Communications|October 30, 1998
Limitations of differential displayP Ledakis, H Tanimura, T FojoPageof 33